AOD-9604 + CJC + Ipamorelin (12mg Triple Blend)
Analytical Standards & Laboratory Handling
Verified laboratory protocols, reconstitution parameters, and handling guidelines.
Pharmacological Profile & Mechanism of Action
What it is: AOD + CJC + Ipam is a triple synergistic blend containing AOD-9604 (6 mg), CJC-1295 No DAC (3 mg), and Ipamorelin (3 mg) in a unified 2:1:1 stoichiometric ratio (12 mg total).
How it works: AOD-9604 directly stimulates adipocyte beta-3 adrenergic receptors to burn stored triglycerides without affecting blood glucose or IGF-1, while CJC-1295 and Ipamorelin elevate endogenous nocturnal GH pulses to accelerate lean tissue recovery.
Why researchers study it: Researched in targeted adipose reduction protocols designed to maximize fat loss while preserving muscle nitrogen balance.
Compound & Molecular Specifications
Certificate of Analysis StandardsAll-in-One Pre-Mixed Peptide Formulation
This product is a Blend (1 physical vial) where active peptide compounds are co-lyophilized into a single cake for simplified reconstitution. If your research requires staggered administration windows (e.g. Fasted AM vs Pre-Bed PM) or custom stoichiometric titrations, you can stack separate vials in our Stacking Studio.
